Tilray Inc. (Nasdaq: TLRY) closed 17% higher at $28,19 after the Ministry of Health and the Medicinal Cannabis Agency of New Zealand have granted Tilray Inc (NASDAQ: TLRY) the first approval under the new Medical Cannabis Scheme to launch medical cannabis products across the country, according to a Press Release. Tilray stocks have already risen 243% for 2021.